Clinical trial
Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary…
NCT00975195 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00975195 |
|---|---|
| Title | Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease |
| Official title | A Randomised, Double-blind, Active-controlled Study to Evaluate the Impact of Stepwise Withdrawal of Inhaled Corticosteroid Treatment in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) on Optimized Bronchodilator Therapy |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | tiotropium inhalation, salmeterol xinafoate, fluticasone propionate, placebo matched for fluticasone propionate |
| Enrollment | 2,488 |
| Start date | Feb 1, 2009 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Sep 11, 2009 |
| Last update posted | Feb 10, 2015 |
| Countries | Australia, Belgium, Brazil, Bulgaria, China, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands and 11 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: